Category: Biomarkers
Global Biomarkers
-
Global Liquid Biopsy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Theranostics Market by Product (Software and Services, Radiopharmaceuticals, IVD/Biomarker Screening, Diagnostic Imaging), Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... was valued at $2.39 billion in 2024 and is projected to reach $5.77 billion by 2030, growing at a CAGR of 15.8% during the forecast period. Theranostics Market Overview Theranostics is a cutting-edge field of ... Read More
-
Global Biomarkers Competitive Landscape Professional Research Report 2024
... organism. They can be found in bodily fluids, tissues, or other biological samples and can provide valuable information about the presence, progression, or severity of a disease, as well as the efficacy of a treatment ... Read More
-
Global Digital Biomarker Competitive Landscape Professional Research Report 2024
... track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters ... Read More
-
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Competitive Landscape Professional Research Report 2024
... that can be used in various medical contexts. Biomarkers are measurable indicators found in biological samples, such as blood, urine, or tissue, that can signal the presence or progression of diseases or provide insights into ... Read More
-
Global Neurological Biomarkers Competitive Landscape Professional Research Report 2024
... physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities or ... Read More
-
Global PD-L1 Biomarker Testing Competitive Landscape Professional Research Report 2024
... on the surface of cancer cells. It plays a crucial role in the field of cancer immunotherapy, particularly in the treatment of solid tumors with immune checkpoint inhibitors. The test involves analyzing tissue samples from ... Read More
-
Biomarkers Market by Product & Service (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease, Application - Global Forecast 2024-2030
... expected to reach USD 59.69 billion in 2024, at a CAGR 14.19% to reach USD 132.98 billion by 2030. Biomarkers, also known as biological markers, a measurable indicators of some biological state or condition, often ... Read More
-
Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030
... 3.11 billion in 2023 and expected to reach USD 3.38 billion in 2024, at a CAGR 9.25% to reach USD 5.78 billion by 2030. A central lab operates as a core facility providing high-quality and ... Read More
-
GI Stool Testing Market by Product (Analyzers, Consumables), Test (Bacteria Test, Fecal Biomarkers Test, Occult Blood Test), Application, End-use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 691.83 million in 2024, at a CAGR 6.67% to reach USD 1,024.26 million by 2030. The GI (Gastrointestinal) stool testing market involves the analysis of fecal samples to ... Read More
-
Cancer/Tumor Profiling Market by Technology (Immunoassays, In-Situ Hybridization, Mass Spectrometry), Biomarker Type (Genomic Biomarker, Protein Biomarker), Cancer Type, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 12.77 billion in 2024, at a CAGR 18.74% to reach USD 35.94 billion by 2030. Cancer/tumor profiling is a laboratory method that analyzes specific proteins, genes, and other molecules ... Read More
-
Genomic Biomarker Market by Product (Consumables, Services, Software), Type (Predictive Biomarkers, Prognostic Biomarkers), Disease Indication, End-User - Global Forecast 2024-2030
... to reach USD 4.67 billion in 2024, at a CAGR 6.67% to reach USD 6.92 billion by 2030. Genomic biomarkers are DNA or RNA molecules that are used to examine the complex relationships between genetics ... Read More
-
Cancer Biomarkers Market by Biomarker Type (Genetic, Protein), Cancer Type (Blood Cancer, Breast Cancer, Colorectal Cancer), Technology, Application, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 31.23 billion in 2024, at a CAGR 10.71% to reach USD 57.75 billion by 2030. Cancer biomarkers are substances or processes that can be measured in parts of ... Read More
-
Cardiac Marker Market by Product (Instruments, Reagents & Kits), Biomarker Type (BNP Or NT-ProBNP, CK-MB, Hs-CRP), End-User, Indication - Global Forecast 2024-2030
... and expected to reach USD 4.16 billion in 2024, at a CAGR 9.71% to reach USD 7.29 billion by 2030. Cardiac markers are substances or molecules measured in the blood to diagnose and monitor various ... Read More
-
Cardiac Point of Care Testing Market by Product (Analyzers, Kits & Assays, Software & Services), Biomarker Type (Cardiac Troponins, CK-MB Fraction, D-Dimer), End-User - Global Forecast 2024-2030
... was estimated at USD 8.31 billion in 2023 and expected to reach USD 9.38 billion in 2024, at a CAGR 13.14% to reach USD 19.74 billion by 2030. Cardiac point of care testing refers to ... Read More
-
Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Global Forecast 2024-2030
... was estimated at USD 964.90 million in 2023 and expected to reach USD 1,031.96 million in 2024, at a CAGR 7.34% to reach USD 1,585.04 million by 2030. Biomarker testing services refer to the clinical ... Read More
-
Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2024-2030
... 5.10 billion in 2023 and expected to reach USD 5.50 billion in 2024, at a CAGR 7.90% to reach USD 8.69 billion by 2030. Cardiac marker testing market consists of the spectrum of medical technologies ... Read More
-
Global Biomarker of Disease Market Growth (Status and Outlook) 2024-2030
... other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and ... Read More
-
Cancer Biomarker Global Market Opportunities And Strategies To 2033
... Risk Assessment4) By Cancer Type: Cervical Cancer; Breast Cancer; Lung Cancer; Brain and Central Nervous System Cancer; Kidney Cancer; Colorectal Cancer; Prostate Cancer; Ovarian Cancer; Stomach CancerCovering: Roche Diagnostics; Novartis AG; Illumina; Hologic Inc.; Thermo ... Read More
-
Global Veterinary Biomarker Test Product Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Veterinary Biomarker Test Product is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
North America Cardiac Markers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Reagents and Kits, and Analyzers), Biomarker Type (Troponin, Creatine Kinase-MB, Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico)
... Myoglobin, B-Type Natriuretic Peptide, and Others), Indication (Congestive Heart Failure, Myocradial Infraction, Acute Coronary Syndrome, and Others), End User (Hospitals, Diagnostic Laboratories, Point-of-Care Testing Facilities, and Others), and Country (US, Canada, Mexico) The global North ... Read More
-
Spatial Transcriptomics Market (Product Type: Consumables, Instruments, and Services; and Application: Clinical, and Drug and Biomarker Discovery and Development) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2034
... of Report TMR’s report on the global spatial transcriptomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast ... Read More
-
2024 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines ... Read More
-
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-cancer (NIPT, Infectious)), Sample Type (Blood) - Global Forecast to 2029
... biopsy market is valued at an estimated USD 6.4 billion in 2024 and is projected to reach USD 11.3 billion by 2029 at a CAGR of 11.9% during the forecast period. Liquid biopsy presents numerous ... Read More
-
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region and Competition, 2019-2029F
... 2019-2029F Global Personalized Medicine Biomarkers Market was valued at USD 14.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In recent years, ... Read More
Research Assistance
